Company news
Terns Pharmaceuticals, Inc. news in 2026
Terns Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.
TERN Awarded $11.26 Million U.S. Army Contract to Deploy Next Generation Positioning, Navigation, and Vehicle Readiness Systems
September 10, 2026
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia
April 27, 2026
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
March 25, 2026
Terns Pharmaceuticals Reports Inducement Grants to New Employees under Nasdaq Listing Rule 5635(4)
February 3, 2026
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
February 2, 2026
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026